{
    "root": "31188305-60b5-bf7f-e063-6294a90ac7f4",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Dicyclomine HCl",
    "value": "20250324",
    "ingredients": [
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26710"
        },
        {
            "name": "DICYCLOMINE HYDROCHLORIDE",
            "code": "CQ903KQA31",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4515"
        }
    ],
    "indications": {
        "text": "dicyclomine hydrochloride injection indicated treatment patients functional bowel/irritable bowel syndrome .",
        "doid_entities": [
            {
                "text": "syndrome (DOID:225)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_225"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "must adjusted individual patient needs .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "dicyclomine hydrochloride injection , usp , 20 mg/2 ml ( 10 mg/ml ) single dose vials , ( im , iv ) supplied follows : ndc 14789-010-02 : boxes 5 vials store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . protect freezing .",
    "adverseReactions": "dicyclomine hydrochloride contraindicated infants less 6 months age [ ( 8.4 ) ] , nursing mothers [ ( 8.3 ) ] , patients : unstable cardiovascular status acute hemorrhage myasthenia gravis [ ( 5.4 ) ] glaucoma [ ( 6.3 ) ( 7.1 ) ] obstructive uropathy [ ( 5.8 ) ] obstructive disease gastrointestinal tract [ ( 5.5 ) ] severe ulcerative colitis [ ( 5.7 ) ] reflux esophagitis",
    "indications_original": "Dicyclomine hydrochloride injection is indicated for the treatment of patients with functional bowel/irritable bowel syndrome.",
    "contraindications_original": "Dosage must be adjusted to individual patient needs.",
    "warningsAndPrecautions_original": "Dicyclomine Hydrochloride Injection, USP, 20 mg/2 mL (10 mg/mL) single dose vials, (\n \n  for IM use only, NOT FOR IV USE) is supplied as follows:\n\n \n                  \n                     NDC 14789-010-02: boxes of 5 vials\n\n \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [See USP Controlled Room Temperature].\n \n  Protect from freezing.",
    "adverseReactions_original": "Dicyclomine hydrochloride is contraindicated in infants less than 6 months of age\n \n  [see Use in Specific Populations(\n  \n   8.4)]\n \n  , nursing mothers\n \n  [see Use in Specific Populations (\n  \n   8.3)]\n \n  , and in patients with:\n\n \n                  \n                     unstable cardiovascular status in acute hemorrhage\n                     myasthenia gravis\n  \n   [see Warnings and Precautions (\n   \n    5.4)]\n  \n   \n                     \n                     glaucoma\n  \n   [see Adverse Reactions (\n   \n    6.3) and Drug Interactions (\n   \n    7.1)]\n  \n   \n                     \n                     obstructive uropathy\n  \n   [see Warnings and Precautions (\n   \n    5.8)]\n  \n   \n                     \n                     obstructive disease of the gastrointestinal tract\n  \n   [see Warnings and Precautions (\n   \n    5.5)]\n  \n   \n                     \n                     severe ulcerative colitis\n  \n   [see Warnings and Precautions (\n   \n    5.7)]\n  \n   \n                     \n                     reflux esophagitis",
    "drug": [
        {
            "name": "Dicyclomine HCl",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4514"
        }
    ]
}